Revista CEFAC

Table of contents previous current next

Table of contents

ORIGINAL ARTICLES • Rev. CEFAC 25 (5) • 2023 • https://doi.org/10.1590/1982-0216/20232553623 linkcopy

Factors associated with mandibular function impairment in people with Parkinson’s disease during social isolation due to COVID-19

Authorship SCIMAGO INSTITUTIONS RANKINGS

Purpose: to analyze factors associated with mandibular function impairment in people with Parkinson’s disease during social isolation due to COVID-19.

Methods: this cross-sectional, quantitative, analytical study used a database with 115 records of patients presented with this condition (obtained via telemonitoring in a research conducted in 2020) and assessed sociodemographic aspects and the Mandibular Function Impairment Questionnaire (MFIQ). The variables addressed in the associations were sex, age, marital status, denture use, disease duration, and daily levodopa dose. Results were obtained with the Fisher´s exact test, with the significance level set at p < 0.05.

Results: after analyzing the database, the final sample comprised 62 eligible records - 61% were males, 79% were above 60 years old, 63% wore dentures, and 93% had low severity of mandibular function impairment, according to MFIQ. No significant associations were found between the study variables and MFIQ (p < 0.05).

Conclusion: the degree of mandibular impairment was low, and the study variables were not associated with mandibular function impairment in patients presented with Parkinson´s disease, during social isolation, due to COVID-19.

Keywords:
Parkinson Disease; COVID-19; Pandemics; Signs and Symptoms; Aged

Variables	n = 62	(%)	Mean ± SD
Age (years)			66±8
< 60	13	21%
> 60	49	79%
Sex
Males	38	61%
Females	24	39%
Marital status
Single	7	11%
Married or in a domestic partnership	45	73%
Widow(er)	4	6%
Separated or divorced	6	10%
Has children?
Yes	58	94%
No	4	6%
Number of children
One	6	10%
Two	25	41%
Three	12	19%
Four or more	15	24%
Parkinson’s disease duration			10±5
0-13 years	47	76%
14-26 years	15	24%
Had COVID-19?
Yes	4	6%
No	54	87%
Tested to diagnose COVID-19?
Yes	5	8%
No	57	92%
COVID-19 test result
Positive	1	20%
Negative	4	80%
Wears dentures?
Yes	39	63%
No	23	37%
Daily levodopa dose
300 - 600 mg	38	55%
> 600 mg	24	45%

Variables (n=39)	Time of denture use
Types of dentures	1 - 15 years	16 - 40 years	Total
Upper complete dentures	5	3	8
Upper and lower complete dentures	1	1	2
Upper complete and lower partial removable dentures	3	3	6
Upper removable partial dentures	3	3	6
Lower removable partial dentures	1	2	3
Upper and lower removable partial dentures	10	2	12
Upper fixed dentures	2	0	2
Total	25	14	39

Variables	MFIQ			p-value*
Sex	Low Degree	Moderate Degree	Total	0.71
Males	34	4	38
Females	24	0	24
Total	58	4	62
Age	Low Degree	Moderate Degree	Total	0.97
< 60	12	1	13
> 60	46	3	49
Total	58	4	62
MS: single	Low Degree	Moderate Degree	Total	0.38
Yes	6	1	7
No	52	3	55
Total	58	4	62
MS: married	Low Degree	Moderate Degree	Total	1.00
Yes	42	3	45
No	16	1	17
Total	58	4	62
MS: widow(er)	Low Degree	Moderate Degree	Total	1.00
Yes	4	0	4
No	54	4	58
Total	58	4	62
MS: separated	Low Degree	Moderate Degree	Total	1.00
Yes	6	0	6
No	52	4	56
Total	58	4	62
Denture use	Low Degree	Moderate Degree	Total	0.62
Yes	37	2	39
No	21	2	23
Total	58	4	62

Variables	MFIQ			p-value*
Duration (0-13 years)	Low Degree	Moderate Degree	Total	0.95
Yes	44	3	47
No	14	1	15
Total	58	4	62
Duration (14-26 years)	Low Degree	Moderate Degree	Total	0.95
Yes	14	1	15
No	44	3	47
Total	58	4	62
Levodopa (300-600 mg)	Low Degree	Moderate Degree	Total	1.00
Yes	32	2	34
No	26	2	28
Total	58	4	62
Levodopa (> 600 mg)	Low Degree	Moderate Degree	Total	1.00
Yes	26	2	28
No	32	2	34
Total	58	4	62

location_on

ABRAMO Associação Brasileira de Motricidade Orofacial Rua Uruguaiana, 516, Cep 13026-001 Campinas SP Brasil, Tel.: +55 19 3254-0342 - São Paulo - SP - Brazil
E-mail: revisora1@revistacefac.com.br

rss_feed Stay informed of issues for this journal through your RSS reader

Report error